Clinical trial
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
NCT00266864 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00266864 |
|---|---|
| Title | Testosterone Replacement Therapy in Chronic Spinal Cord Injury |
| Official title | Testosterone Replacement Therapy in Chronic Spinal Cord Injury |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Collaborators | Kessler Institute for Rehabilitation Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Spinal Cord Injury, Hypogonadism |
| Intervention type | Drug |
| Interventions | Testosterone Transdermal System (Androderm 5 mg patch) |
| Enrollment | 31 |
| Start date | Aug 1, 2003 |
| Primary completion | Aug 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Dec 19, 2005 |
| Last update posted | Nov 1, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: